GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently gaining a significant focus in healthcare studies, largely due to its notable impact on controlling ailments such as adult-onset diabetes and obesity. Ongoing research have demonstrated that more than glucose regulation, GLP-1 drugs offer promise for cardiovascular function an